Taking everything into account, HSTO scores 3 out of 10 in our fundamental rating. HSTO was compared to 524 industry peers in the Biotechnology industry. While HSTO seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, HSTO is valued expensive at the moment.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year HSTO has reported negative net income.
HSTO had a negative operating cash flow in the past year.

1.2 Ratios

The Return On Assets of HSTO (-89.51%) is worse than 75.58% of its industry peers.
HSTO has a Return On Equity of -130.43%. This is in the lower half of the industry: HSTO underperforms 66.50% of its industry peers.

		Industry Rank	Sector Rank
ROA	-89.51%
ROE	-130.43%
ROIC	N/A

ROA(3y)-79.39%

ROA(5y)-75.22%

ROE(3y)-128.82%

ROE(5y)-120.14%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HSTO has a better Gross Margin (19836.80%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of HSTO has grown nicely.
HSTO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	19836.8%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y6.8%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HSTO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HSTO has been increased compared to 1 year ago.
The debt/assets ratio for HSTO has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -11.61, we must say that HSTO is in the distress zone and has some risk of bankruptcy.
HSTO's Altman-Z score of -11.61 is on the low side compared to the rest of the industry. HSTO is outperformed by 81.35% of its industry peers.
There is no outstanding debt for HSTO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-11.61

ROIC/WACCN/A

WACC9.53%

2.3 Liquidity

HSTO has a Current Ratio of 8.54. This indicates that HSTO is financially healthy and has no problem in meeting its short term obligations.
HSTO has a better Current ratio (8.54) than 66.67% of its industry peers.
HSTO has a Quick Ratio of 8.54. This indicates that HSTO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of HSTO (8.54) is better than 66.83% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	8.54
Quick Ratio	8.54

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.01% over the past year.
HSTO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -99.56%.
The Revenue for HSTO have been decreasing by -36.10% on average. This is quite bad

EPS 1Y (TTM)41.01%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%68.39%

Revenue 1Y (TTM)-99.56%

Revenue growth 3Y-30.95%

Revenue growth 5Y-36.1%

Sales Q2Q%0%

3.2 Future

The Earnings Per Share is expected to grow by 30.21% on average over the next years. This is a very strong growth
Based on estimates for the next years, HSTO will show a very strong growth in Revenue. The Revenue will grow by 85.81% on average per year.

EPS Next Y26.45%

EPS Next 2Y9.45%

EPS Next 3Y4.01%

EPS Next 5Y30.21%

Revenue Next Year-99.88%

Revenue Next 2Y-41.42%

Revenue Next 3Y-25.99%

Revenue Next 5Y85.81%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HSTO. In the last year negative earnings were reported.
Also next year HSTO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.